biote Corp. (BTMD) vs Dogwood Therapeutics, Inc. (DWTX)
A side-by-side comparison of biote Corp. and Dogwood Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BTMD
biote Corp.
$1.19HealthcareDelayed quote: Oct 6, 2026, 12:08 PM EDT
DWTX
Dogwood Therapeutics, Inc.
$1.56HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT
Total return — BTMD vs DWTX
growth of $100 · dividends reinvested · last 5yBTMD -88.9% (-35.5%/yr)DWTX -98.9% (-59.5%/yr)BTMD compounded faster over this window
Log scale — wide-divergence pair
BTMD DWTX
BTMD vs DWTX: by the numbers
- •BTMD is the larger company ($52M vs $52M market cap).
- •BTMD is profitable (3.19% net margin) while DWTX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | BTMD | DWTX |
|---|---|---|
| P/E ratio | 10.20 | N/A |
| P/S ratio | 0.29 | N/A |
| P/B ratio | N/A | 0.77 |
| EV / EBITDA | 9.14 | N/A |
| FCF yield | 37.50% | N/A |
Profitability
| Metric | BTMD | DWTX |
|---|---|---|
| Gross margin | 71.46% | 0.00% |
| Operating margin | 18.50% | 0.00% |
| Net margin | 3.19% | 0.00% |
| ROE | N/A | -52.72% |
| ROIC | 13.63% | -38.04% |
Growth (annualized)
| Metric | BTMD | DWTX |
|---|---|---|
| Revenue CAGR (5Y) | 10.52% | N/A |
| EPS CAGR (5Y) | -25.90% | N/A |
| FCF CAGR (5Y) | 3.81% | N/A |
| Total return CAGR (5Y) | -35.12% | -58.44% |
Frequently asked
- Is BTMD or DWTX more profitable?
- BTMD runs the higher net margin — BTMD at 3.19% versus DWTX at 0.00%.
- How have BTMD and DWTX total returns compared?
- Over the past 5 years, BTMD delivered -35.12% and DWTX delivered -58.44% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
biote P/E ratiobiote ROEDogwood Therapeutics ROEbiote operating marginDogwood Therapeutics operating marginbiote revenue growthDogwood Therapeutics revenue growthbiote free cash flowDogwood Therapeutics free cash flow
biote & Dogwood Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.